Register for metastatic breast cancer patients in Austria
Part of Cancer, Skin clinical trials.
This trial is a non-treatment registry that collects information about people with metastatic breast cancer in Austria. It may help researchers better understand the disease and outcomes over time by tracking real-world patient details.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a confirmed diagnosis of breast cancer confirmed by tissue (biopsy) results
- Your cancer must have spread to other parts of the body (confirmed by tissue and/or scans)
- The spread must have happened within the past 10 years of the registry starting
- You must be able to join the study paperwork (signed consent), unless you can’t because you are already deceased
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects tissue samples and health information from people with breast cancer that has spread or come back. It aims to help researchers learn more about the disease and may lead to better treatments.
This registry collects information from adults with lymphoma to better understand the disease and improve future treatments. It is open to all patients 18 or older with lymphoma.
This study tracks people with metastatic colorectal cancer who have already tried at least two standard treatments. It aims to collect real-world data on how well newer treatments work in later lines of therapy.
This study collects health and treatment information from people with breast cancer that cannot be fully removed by surgery or that has spread to other parts of the body. It may help researchers better understand which treatments are used and how people do over time.
This study is creating a registry to track information about people with bone metastases (cancer that has spread to the bones) who need treatment for symptoms. It may help researchers learn more about these conditions.
This is a registry study that collects information from people with myeloid blood diseases. It helps researchers better understand these conditions and support future research.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.